RESHAPE LIFESCIENCES INC (RSLS) Stock Income Statement
NASDAQ:RSLS - Nasdaq - US76090R3093 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.17M | 8.01M | 8.68M | 11.24M | 13.60M | |||
| Cost Of Goods | 2.60M | 2.95M | 3.13M | 4.44M | 5.25M | |||
| Gross Profit | 4.57M | 5.06M | 5.55M | 6.80M | 8.35M | |||
| Operating Expenses | 10.87M | 11.72M | 20.19M | 33.88M | 35.58M | |||
| Research and Development | 1.68M | 1.80M | 2.31M | 2.54M | 2.37M | |||
| Selling, General, and Administrative Expenses | 9.19M | 9.92M | 17.87M | 31.34M | 33.21M | |||
| Operating Income | -6.30M | -6.67M | -14.64M | -27.08M | -27.23M | |||
| Interest Income/Expense | 3.62M | 15.00K | 3.93M | -250.00K | -660.00K | |||
| Other Income/Expense | 222.00K | 193.00K | 122.00K | 10.00K | -2.81M | |||
| Non Recurring Items | -974.00K | -631.00K | -744.00K | -19.27M | -32.71M | |||
| Income Before Taxes | -3.43M | -7.09M | -11.34M | -46.59M | -63.42M | |||
| Income Tax | 33.00K | 39.00K | 52.00K | -380.00K | -270.00K | |||
| Net Income | -3.46M | -7.13M | -11.39M | -46.21M | -63.15M | |||
| EBITDA | -6.28M | -6.65M | -14.48M | -24.93M | -25.26M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -212.11 | -345.78 | -2.77K | -159.34K | -421.00K | |||
| Non GAAP EPS | N/A | N/A | -5.15K | -118.31K | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 63.74% | 63.17% | 63.93% | 60.50% | 61.40% | |||
| Profit Margin | -48.26% | -89.06% | -131.22% | -411.12% | -464.34% | |||
| Operating Profit Margin | -87.75% | -83.29% | -168.69% | -240.93% | -200.22% | |||
All data in USD